Differential expression of junctional adhesion molecules in different stages of systemic sclerosis
Tommaso Mello
Arthritis & Rheumatism, 2013
View PDFchevron_right
Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study
Giovanni Lapadula
The Journal of rheumatology, 2005
View PDFchevron_right
The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1
Bradley Rabquer
Rheumatology, 2009
View PDFchevron_right
Clinical implications of soluble intercellular adhesion molecule-1 levels in systemic sclerosis
Gwen Kennedy
Rheumatology, 1998
View PDFchevron_right
Adhesion of peripheral blood mononuclear cells to vascular endothelium in patients with systemic sclerosis (scleroderma)
Slawomir Majewski
Arthritis & Rheumatism, 1992
View PDFchevron_right
Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma
H. Ihn
Journal of the American Academy of Dermatology, 1994
View PDFchevron_right
Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis
Maria Orietta Borghi
Arthritis & Rheumatism, 2002
View PDFchevron_right
Expression and shedding of intercellular adhesion molecule 1 and lymphocyte function–associated antigen 3 by normal and scleroderma fibroblasts
David Abraham
Arthritis & Rheumatism, 1994
View PDFchevron_right
Fibrotic phenotype of Systemic Sclerosis fibroblasts varies with disease duration and severity of skin involvment
Stéphane Chabaud
The Journal of Pathology
View PDFchevron_right
Junctional Adhesion Molecules (JAM)-B and -C Contribute to Leukocyte Extravasation to the Skin and Mediate Cutaneous Inflammation
Heinfried Radeke
Journal of Investigative Dermatology, 2005
View PDFchevron_right
Systemic sclerosis sera affect fibrillin-1 deposition and focal adhesion molecule expression by dermal blood microvascular endothelial cells: Therapeutic implications of cyclophosphamide
piersante sestini
Italian journal of anatomy and embryology, 2013
View PDFchevron_right
Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis
J. Avouac
Annals of the Rheumatic Diseases, 2013
View PDFchevron_right
Skin involvement in systemic sclerosis
László Czirják
Rheumatology, 2008
View PDFchevron_right
Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis
Henry Lopez
Arthritis Research & Therapy, 2015
View PDFchevron_right
The vascular basement membrane in systemic sclerosis skin: heterogeneity of type IV collagen
Tony Freemont
British Journal of Dermatology, 1993
View PDFchevron_right
Systemic sclerosis: current views of its pathogenesis
Sergio Jimenez
Autoimmunity Reviews, 2003
View PDFchevron_right
Vascular damage and lack of angiogenesis in systemic sclerosis skin
Zygmunt Mackiewicz
Clinical Rheumatology, 2003
View PDFchevron_right
Skin involvement in scleroderma--where histological and clinical scores meet
dominique FARGE
Rheumatology, 2007
View PDFchevron_right
Increased serum levels of soluble vascular cell adhesion molecule-1 and E-selectin in patients with systemic sclerosis
H. Ihn
Rheumatology, 1998
View PDFchevron_right
B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis
Ghada Alsaleh
Arthritis Research & Therapy, 2013
View PDFchevron_right
Peripheral T lymphocytes from patients with early systemic sclerosis co-cultured with autologous fibroblasts undergo an oligoclonal expansion similar to that occurring in the skin
Gabriele Valentini
Clinical and Experimental Immunology, 2006
View PDFchevron_right
a4b1 + and a4b7 + CD4 + T cell numbers increase and CLA + CD4 + T cell numbers decrease in systemic sclerosis
Roberto Paganelli
Clinical & Experimental Immunology, 2005
View PDFchevron_right
Cell Adhesion Molecules in Skin Diseases: New Perspectives in Molecular Dermatopathology
Max Solano
Baylor University Medical Center Proceedings
View PDFchevron_right
Immunologic Parameters in Systemic Sclerosis
U.-F. Haustein
International Journal of Dermatology, 1994
View PDFchevron_right
The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach
Stéphane Chabaud
The Journal of Pathology, 2009
View PDFchevron_right
Dermal tissue and cellular expression of fibrillin-1 in diffuse cutaneous systemic sclerosis
J. Avouac
Rheumatology, 2010
View PDFchevron_right
Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea
Marzia Caproni
British Journal of Dermatology, 2010
View PDFchevron_right
Assessment of skin involvement in systemic sclerosis
Daniela Opris-Belinski
Rheumatology, 2017
View PDFchevron_right
Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta
Sergio Jimenez
Journal of Clinical Investigation, 1994
View PDFchevron_right
Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestations
Pravin Hissaria
Clinical rheumatology, 2018
View PDFchevron_right
Pathogenic autoantibodies in systemic sclerosis
Gianluca Moroncini
Current Opinion in Immunology, 2007
View PDFchevron_right
Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation
Simeon Goldblum
The Journal of rheumatology, 2002
View PDFchevron_right